Recent research into the microbiome demonstrates that the composition of gut microbiota influences the development and progression of disease. However, more research is needed to fully strengthen this connection. Taconic's Dr. Alexander Maue recently authored an article for Drug Discovery World depicting the investment landscape of biotech and pharmaceutical companies in the microbiome field. Dr. Maue describes how the number of IPOs, mergers & acquisitions, collaborations, and venture capital investments all contribute to furthering this field of research.
Read the complete article at: Drug Discovery World
Read the complete article at: Drug Discovery World